Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.

Authors

Theresa Maitz DO, Lehigh Valley Health NetworkFollow
Rahul Gupta MD, Lehigh Valley Health NetworkFollow
Kathryn Persin, Dartmouth University
Deborah W Sundlof DO, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

6-15-2022

Abstract

Arrhythmogenic right ventricular (RV) cardiomyopathy is an autosomal dominant inherited cardiomyopathy that is characterized by an increased risk of ventricular arrhythmias, sudden cardiac death and, less commonly, heart failure. The authors present the case of a 36-year-old woman with familial lamin cardiomyopathy with positive

ISSN

1744-8298

Published In/Presented At

Maitz TN, Gupta R, Persin K, Sundlof DW. Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy. Future Cardiol. 2022 Jun 15. doi: 10.2217/fca-2021-0148. Epub ahead of print. PMID: 35703395.

Disciplines

Medicine and Health Sciences

PubMedID

35703395

Department(s)

Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents, Fellows and Residents

Document Type

Article